The following discloses our information gathering and dissemination practices for the canSAR.ai
We may use your IP address to help diagnose problems with our server and to administer our website by
identifying (1) which parts of our site are most heavily used, and (2) which portion of our audience
comes from within the MD Anderson Institute of Data Science in Oncology network. We do not link IP
addresses to anything personally identifiable. This means that user sessions will be tracked, but the
web browser, but if you choose not to accept cookies you will not be able to take full advantage of
all of the website's features.
Use of information
MD Anderson Institute of Data Science in Oncology staff uses the information gathered above to tailor
site content to user needs, and to generate aggregate statistical reports. At no time do we disclose
site usage by individual IP addresses. Web server logs are retained on a temporary basis and then
deleted completely from our systems.
This site has security measures in place to protect the loss, misuse and alteration of the information
under our control. MD Anderson Institute of Data Science in Oncology however, is not liable for the
loss, misuse or alteration of information on this site by any third party.
We reserve the right to amend this cookie statement. If we do so, we will post notice of the change on
our website and you will be deemed to have accepted such changes. This statement was last updated on
November 15, 2022.
The effective date of this policy is December 16, 2022.
Kindly cite canSAR:
canSAR: update to the cancer translational research and drug discovery knowledgebase, Costas
Mitsopoulos, Patrizio Di Micco, Eloy Villasclaras Fernandez, Daniela Dolciami, Esty Holt, Ioan L.
Mica, Elizabeth A. Coker, Joseph E. Tym, James Campbell, Ka Hing Che, Bugra Ozer, Christos Kannas,
Albert A. Antolin, Paul Workman, Bissan Al-Lazikani,
Nucl. Acids Res. 2021 Jan 8;49(D1):D1074-D1082. doi: